Reported functional studies of these cancer-associated Aα variants have confirmed their increased oncogenic potential in cancer cell growth, migration, and drug resistance, but as this is the first reported case of PPP2R1A with a malignancy, it is unclear whether this is mainly coincidental or part of the clinical phenotype of the more severely affected PPP2R1A subgroup [16]. This evidence concerns the gene PPP2R1A and cancer.